M. Bonarek

1.0k total citations
15 papers, 552 citations indexed

About

M. Bonarek is a scholar working on Infectious Diseases, Epidemiology and Emergency Medicine. According to data from OpenAlex, M. Bonarek has authored 15 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 5 papers in Epidemiology and 5 papers in Emergency Medicine. Recurrent topics in M. Bonarek's work include HIV/AIDS drug development and treatment (8 papers), HIV/AIDS Research and Interventions (5 papers) and HIV-related health complications and treatments (5 papers). M. Bonarek is often cited by papers focused on HIV/AIDS drug development and treatment (8 papers), HIV/AIDS Research and Interventions (5 papers) and HIV-related health complications and treatments (5 papers). M. Bonarek collaborates with scholars based in France. M. Bonarek's co-authors include Fabrice Bonnet, J Beylot, N. Bernard, B. Dubroca, Pascale Barberger‐Gateau, A. Iron, Valérie Deschamps, Luc Letenneur, Julie Galimand and A Venet and has published in prestigious journals such as Clinical Infectious Diseases, Kidney International and Digestive Diseases and Sciences.

In The Last Decade

M. Bonarek

15 papers receiving 531 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Bonarek France 11 257 203 127 82 82 15 552
Eduardo Shahar Israel 12 180 0.7× 131 0.6× 61 0.5× 7 0.1× 38 0.5× 33 550
Jean-Marie Idatte France 9 96 0.4× 33 0.2× 62 0.5× 21 0.3× 47 0.6× 18 322
Meghan N. Feldpausch United States 13 77 0.3× 75 0.4× 223 1.8× 81 1.0× 211 2.6× 30 599
María del Mar Gutiérrez Spain 15 265 1.0× 227 1.1× 119 0.9× 25 0.3× 291 3.5× 36 582
Suman Srinivasa United States 15 217 0.8× 231 1.1× 143 1.1× 9 0.1× 514 6.3× 43 802
Ditte Marie Kirkegaard-Klitbo Denmark 9 63 0.2× 21 0.1× 124 1.0× 45 0.5× 93 1.1× 17 312
Camilla Ingrid Hatleberg Denmark 11 235 0.9× 121 0.6× 84 0.7× 11 0.1× 298 3.6× 19 409
Carlee Moser United States 16 402 1.6× 319 1.6× 138 1.1× 18 0.2× 497 6.1× 50 1.0k
Samuel Weinstein United States 13 57 0.2× 31 0.2× 79 0.6× 15 0.2× 29 0.4× 21 570
Gabriella Di Lorenzo Italy 12 144 0.6× 85 0.4× 396 3.1× 351 4.3× 173 2.1× 14 751

Countries citing papers authored by M. Bonarek

Since Specialization
Citations

This map shows the geographic impact of M. Bonarek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Bonarek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Bonarek more than expected).

Fields of papers citing papers by M. Bonarek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Bonarek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Bonarek. The network helps show where M. Bonarek may publish in the future.

Co-authorship network of co-authors of M. Bonarek

This figure shows the co-authorship network connecting the top 25 collaborators of M. Bonarek. A scholar is included among the top collaborators of M. Bonarek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Bonarek. M. Bonarek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Pellegrin, Isabelle, Linda Wittkop, D. Neau, et al.. (2008). Virological Response to Darunavir/Ritonavir-Based Regimens in Antiretroviral-Experienced Patients (PREDIZISTA Study). Antiviral Therapy. 13(2). 271–280. 21 indexed citations
2.
Goujard, Cécile, M. Bonarek, Laurence Meyer, et al.. (2006). CD4 Cell Count and HIV DNA Level Are Independent Predictors of Disease Progression after Primary HIV Type 1 Infection in Untreated Patients. Clinical Infectious Diseases. 42(5). 709–715. 153 indexed citations
3.
Seydi, Moussa, Philippe Morlat, Fabrice Bonnet, et al.. (2005). Efficacité et tolérance de l'association interféron pégylé-ribavirine chez les patients co-infectés VIH-VHC en pratique clinique : étude observationnelle de 32 patients. La Revue de Médecine Interne. 26(4). 280–287. 3 indexed citations
4.
Bani‐Sadr, Firouzé, Fabrice Carrat, Éric Rosenthal, et al.. (2005). Spontaneous Hepatic Decompensation in Patients Coinfected with HIV and Hepatitis C Virus during Interferon-Ribavirin Combination Treatment. Clinical Infectious Diseases. 41(12). 1806–1809. 31 indexed citations
5.
Rubio-Terrés, Carlos, et al.. (2005). The adherence to antiretroviral treatment evaluated from a hospital pharmacy: importance of the protease inhibitors pharmacological class. International Journal of STD & AIDS. 16(5). 379–382. 4 indexed citations
6.
Bonnet, Fabrice, M. Bonarek, P. Mercié, et al.. (2003). Acidose lactique sévère chez les patients infectés par le VIH traités par inhibiteurs nucléosidiques de la reverse transcriptase : 9 cas. La Revue de Médecine Interne. 24(1). 11–16. 11 indexed citations
7.
Bonnet, Fabrice, M. Bonarek, Philippe Morlat, et al.. (2003). Risk Factors for Lactic Acidosis in HIV‐Infected Patients Treated with Nucleoside Reverse‐Transcriptase Inhibitors: A Case‐Control Study. Clinical Infectious Diseases. 36(10). 1324–1328. 45 indexed citations
8.
Bonnet, Fabrice, Jean‐Luc Taupin, Anne Feyler, et al.. (2003). Prevalence of cryoglobulinemia and serological markers of autoimmunity in human immunodeficiency virus infected individuals: a cross-sectional study of 97 patients.. PubMed. 30(9). 2005–10. 44 indexed citations
9.
Bonnet, Fabrice, S. Lawson‐Ayayi, Rodolphe Thiébaut, et al.. (2002). A Cohort Study of Nevirapine Tolerance in Clinical Practice: French Aquitaine Cohort, 1997–1999. Clinical Infectious Diseases. 35(10). 1231–1237. 41 indexed citations
10.
Bonnet, Fabrice, Philippe Morlat, S Witte, et al.. (2002). CASE REPORT: Sarcoidosis-Associated Hepatitis C Virus Infection. Digestive Diseases and Sciences. 47(4). 794–796. 19 indexed citations
11.
Bonarek, M., P. Morlat, Geneviève Chêne, et al.. (2001). Prognostic score of short-term survival in HIV-infected patients admitted to medical intensive care units. International Journal of STD & AIDS. 12(4). 239–244. 14 indexed citations
12.
Bonarek, M., Philippe Morlat, I. Delèvaux, et al.. (2001). The absence of hyperbilirubinaemia is highly predictive of treatment failure in advanced HIV-infected patients treated with indinavir. International Journal of STD & AIDS. 12(1). 29–33. 1 indexed citations
13.
Bonarek, M., Pascale Barberger‐Gateau, Luc Letenneur, et al.. (2000). Relationships between Cholesterol, Apolipoprotein E Polymorphism and Dementia: A Cross-Sectional Analysis from the PAQUID Study. Neuroepidemiology. 19(3). 141–148. 97 indexed citations
14.
Bonarek, Hervé, Pierre Merville, M. Bonarek, et al.. (2000). Improvement of parathyroid function after kidney transplantation: effect on parathyroid functional mass. Transplantation Proceedings. 32(2). 401–403. 1 indexed citations
15.
Bonarek, Hervé, Pierre Merville, M. Bonarek, et al.. (1999). Reduced parathyroid functional mass after successful kidney transplantation. Kidney International. 56(2). 642–649. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026